“These 2 “Strong Buy” Penny Stocks Could Go Boom, Says Roth Capital”
December 2, 2020
“Cellectar Biosciences (CLRB)…
Are other analysts in agreement? They are. 5 Buys and no Holds or Sells have been issued in the last three months. So, the message is clear: CLRB is a Strong Buy. Given the $5.48 average price target, shares could soar 345% from current levels…
Applied Genetic Technologies (AGTC)…
All in all, other analysts echo Jallah’s sentiment. 5 Buys and zero Holds or Sells add up to a Strong Buy consensus rating. The average price target of $18.25 is less aggressive than Jallah’s but still leaves room for upside potential of 306%…”
https://finance.yahoo.com/news/2-strong-buy-penny-stocks-163558205.html